申请人:E. I. Du Pont de Nemours & Co.
公开号:US04415736A1
公开(公告)日:1983-11-15
Process for preparing analgesic and narcotic antagonistic isoquinolines comprising: (a) contacting and reacting a lithiated anisole or alkyl phenyl ether, optionally substituted at the 3-position to the lithium atom, with a 4-piperidone to yield a 4-aryl-4-piperidinol; (b) dehydrating the piperidinol to a 4-aryl-1,2,3,6-tetrahydropyridine; (c) metalating and acylating the 1,2,3,6-tetrahydropyridine to yield a 1-(4-aryl-1,2,3,4-tetrahydropyrid-4-yl)-4-hydroxy-1-butanone; (d) reducing the ketone moiety of the butanone to yield a 5-aryl-7-oxa-2-azabicyclo[3.2.1]-octane-6-propanol; (e) converting the alcohol moiety of the propanol to L to yield a 5-aryl-6-[3-(L)propyl]-7-oxa-2-azabicyclo[3.2.1]octane in which L is a leaving group selected from the group consisting of -Cl, -Br, -I, p-MeC.sub.6 H.sub.4 SO.sub.3 - and MeSO.sub.3 -. (f) opening the amino furan ring of the bicyclooctane to yield a 4-(L)-1-(4-aryl-1,2,3,4-tetrahydropyrid-4-yl)-1-butanol derivative; (g) closing the 6-carbon ring of the butanol derivative by intramolecular reaction of the enamine and leaving group to yield a 4a-aryl-2,3,4,4a,5,6,7,8-octahydro-5-isoquinolinol or derivative thereof; and (h) reducing the enamine double bond of the octahydro-5-isoquinolinol or derivative thereof to yield a 4a-aryldecahydro-5-isoquinolinol or derivative thereof and (i) cyclizing the decahydro-5-isoquinolinol or derivative to yield a 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro-[3,2-e]isoquinoline, or, (h) cyclizing the octahydro-5-isoquinolinol or derivative thereof to yield a 2,3,5,6,7,7a-hexahydro-1H-benzofuro-[3,2-e]isoquinoline and (i) reducing the enamine double bond of the isoquinoline.
制备镇痛剂和镇痛拮抗剂异喹啉的过程包括:(a)将锂化的苯甲醚或烷基苯基醚与4-哌啶酮接触并反应,可选地在3-位替换到锂原子,以产生4-芳基-4-哌啶醇;(b)脱水哌啶醇以得到4-芳基-1,2,3,6-四氢吡啶;(c)金属化和酰化1,2,3,6-四氢吡啶以得到1-(4-芳基-1,2,3,4-四氢吡啶-4-基)-4-羟基-1-丁酮;(d)还原丁酮的酮基以得到5-芳基-7-氧杂-2-氮杂双环[3.2.1]-辛烷-6-丙醇;(e)将丙醇的羟基转化为L,以得到5-芳基-6-[3-(L)丙基]-7-氧杂-2-氮杂双环[3.2.1]辛烷,其中L是从-Cl、-Br、-I、p-MeC.sub.6 H.sub.4 SO.sub.3 -和MeSO.sub.3 -中选择的脱离基;(f)打开双环辛烷的氨基呋喃环以得到4-(L)-1-(4-芳基-1,2,3,4-四氢吡啶-4-基)-1-丁醇衍生物;(g)通过烯胺和脱离基的分子内反应关闭丁醇衍生物的6-碳环以得到4a-芳基-2,3,4,4a,5,6,7,8-辛氢-5-异喹啉醇或其衍生物;(h)还原辛氢-5-异喹啉醇或其衍生物的烯胺双键以得到4a-芳基-十氢-5-异喹啉醇或其衍生物,以及(i)环化十氢-5-异喹啉醇或其衍生物以得到2,3,4,4a,5,6,7,7a-辛氢-1H-苯并呋喃-[3,2-e]异喹啉,或者,(h)环化辛氢-5-异喹啉醇或其衍生物以得到2,3,5,6,7,7a-六氢-1H-苯并呋喃-[3,2-e]异喹啉,以及(i)还原异喹啉的烯胺双键。